Section 21-309.2 – Seasonal Farmer’s Market Producer Sampling License
(a) A county may establish a seasonal farmer’s market producer sampling license to be required for a producer of a farm product to prepare and offer samples of the farm product for human consumption at a farmer’s market or at a public festival or event. (b) A county seasonal farmer’s market producer sampling license established under this […]
Section 21-310 – Issuance and Scope of License
(a) Within 30 days after the Department receives an application for a license, the Department shall issue a license to any applicant who meets the requirements of this subtitle and all regulations adopted under this subtitle. (b) While it is effective, a license authorizes the licensee to operate the food establishment identified on the license.
Section 21-2B-05 – Private Cause of Action Not Created
This subtitle does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against another person involved in the care of an eligible patient using the investigational drug, biological product, or device for any harm to the eligible patient resulting from the investigational drug, biological product, […]
Section 21-2C-15 – Appeals of Board Decisions
(a) A person aggrieved by a decision of the Board may request an appeal of the decision within 30 days after the finding of the Board. (b) The Board shall hear the appeal and make a final decision within 60 days after the appeal is requested. (c) Any person aggrieved by a final decision of the Board may […]
Section 21-2B-06 – Health Insurance Coverage Not Affected
This subtitle does not affect the coverage requirements under Title 15, Subtitle 8 of the Insurance Article.
Section 21-2C-16 – Board and Stakeholder Council Report and Recommendation Concerning Upper Payment Limits
On or before December 1, 2023, the Board, in consultation with the Stakeholder Council, shall report to the Senate Finance Committee and the House Health and Government Operations Committee, in accordance with § 2–1257 of the State Government Article, on: (1) The legality, obstacles, and benefits of setting upper payment limits on all purchases and payor […]
Section 21-2C-01 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Biologic” means a drug that is produced or distributed in accordance with a biologics license application approved under 42 C.F.R. § 447.502. (c) “Biosimilar” means a drug that is produced or distributed in accordance with a biologics license application approved under 42 U.S.C. § 262(k)(3). (d) “Board” […]
Section 21-301 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) (1) “Bottled water” means any water that is sealed in bottles, packages, or other containers and offered for sale for human consumption, including bottled mineral water. (2) “Bottled water” does not include: (i) Soft drinks; or (ii) A beverage that is labeled “club soda” or “seltzer water”. (b–1) “Cottage food […]
Section 21-2C-02 – Prescription Drug Affordability Board
(a) (1) There is a Prescription Drug Affordability Board. (2) (i) The Board is a body politic and corporate and is an instrumentality of the State. (ii) The Board is an independent unit of State government. (iii) The exercise by the Board of its authority under this subtitle is an essential governmental function. (b) The purpose of the Board is to protect […]
Section 21-2C-03 – Membership
(a) (1) The Board consists of the following members, who must have expertise in health care economics or clinical medicine: (i) One member appointed by the Governor; (ii) One member appointed by the President of the Senate; (iii) One member appointed by the Speaker of the House of Delegates; (iv) One member appointed by the Attorney General; and (v) One member appointed […]